FMC stock snapshot and recent performance
FMC (FMC) has drawn attention recently as the stock sits around $13.66, with a market value near $1.7b and share performance under pressure over the past year and past 3 months.
Returns have been mixed in the short term, with the stock up about 0.7% over the past day and roughly 4.2% over the past week, while it is down about 7.8% over the past month.
Over longer periods, the stock has declined about 4.7% year to date, about 64.9% over the past year, and about 85.6% and 86.5% over the past 3 and 5 years respectively, pointing to a tough stretch for long term holders.
See our latest analysis for FMC.
Recent trading has been choppy, with a modest positive 7 day share price return contrasting with a much weaker 1 year total shareholder return. This currently signals pressure rather than momentum.
If you are reassessing FMC after this long slump, it can be useful to look at other materials focused ideas using a rare earth and metals themed screener such as 31 best rare earth metal stocks
With FMC trading around $13.66 after a steep multiyear slump, and showing annual revenue growth alongside a large net loss, is the current valuation reflecting a bargain in a troubled business, or is the market already pricing in its future path?
Most Popular Narrative: 22.1% Undervalued
FMC's most followed valuation narrative pegs fair value at $17.53, above the last close at $13.66, framing the stock as trading at a sizeable discount.
Strong volume growth is expected from recently launched proprietary actives (fluindapyr, Isoflex, Dodhylex) and robust demand in high-growth regions such as Brazil and EMEA, positioning FMC to benefit from global population growth and rising food demand, drivers that are likely to accelerate topline revenue growth.
Analysts blend projected revenue gains, a sharp earnings swing from a multi billion dollar loss, and a re rated profit multiple to reach that fair value. Want to see how those moving parts fit together and what kind of margin profile they are baking in over the next few years?
Result: Fair Value of $17.53 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on FMC managing regulatory pressure and generic competition while also preventing product pricing and margin headwinds from lasting longer than analysts expect.
Find out about the key risks to this FMC narrative.
Next Steps
With sentiment clearly split between pressure and potential, it makes sense to move quickly, review the numbers yourself, and decide where you stand. To see both sides of the story in one place, start with these 3 key rewards and 2 important warning signs.
Looking for more investment ideas?
If FMC is on your radar, do not stop there. Widen your watchlist now so you are not the one hearing about the next opportunity after it moves.
- Spot potential bargains early by scanning a focused set of 46 high quality undervalued stocks with stronger fundamentals than their current prices might suggest.
- Build a steadier core in your portfolio by reviewing a hand picked group of 10 dividend fortresses that prioritize consistent shareholder payouts.
- Reduce surprises by concentrating on 63 resilient stocks with low risk scores that pair financial resilience with lower overall risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com